Cancer - HealthQuill

AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to acquire ImmunoGen, Inc., for $10.1 billion. Image Credit: AbbVie

AbbVie to buy Immunogen for $10.1b to expand solid tumour market

HQ Team November 30, 2023: AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to.

by HealthQuill
November 30, 2023
0 Comments

India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to treat leukaemia and cancer of the lymphatic system.

Drugs Health Pharma

ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India

HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.

by HealthQuill
October 16, 2023
0 Comments

Eli Lilly and Company announced its experimental drug for treating severe Crohn's disease met secondary targets in efficacy and safety.

Drugs Health Pharma

Eli Lilly late-stage trial drug for Crohn’s disease meets testing goals

HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy.

by HealthQuill
October 13, 2023
0 Comments

The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.

Drugs Health Pharma

FDA nod for Pfizer’s combination therapy for non-small cell cancer

HQ Team October 12, 2023: The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer. The FDA.

by HealthQuill
October 12, 2023
0 Comments

Egypt has been granted a “gold tier” status by the WHO for providing 93% of those diagnosed with hepatitis C with treatment in its path to eliminate the infection.

Drugs Health Pharma

Egypt close to ending hepatitis C, gets WHO ‘gold tier’ status

HQ Team October 9, 2023: Egypt has been granted a “gold tier” status by the WHO for providing 93% of those diagnosed with.

by HealthQuill
October 9, 2023
0 Comments

Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through a combination of cash and debt to broaden its cancer portfolio.

Drugs Health Pharma

Bristol Myers acquires Mirati Therapeutics for $5.8 billion

HQ Team October 9, 2023: Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through.

by HealthQuill
October 9, 2023
0 Comments

Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency often ignored by caretakers.

Drugs Health Pharma

US cancer patients using alcohol pose new challenge for caretakers

Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency.

by HealthQuill
September 17, 2023
0 Comments

https://investors.immatics.com/news-releases/news-release-details/moderna-and-immatics-announce-strategic-multi-platform

Drugs Health Pharma

Moderna, Immatics join hands to hunt for cancer therapies using mRNA, AI

HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a.